Exploring Elevance Health Inc. (ELV) Investor Profile: Who’s Buying and Why?

Have you ever wondered who the major players are behind Elevance Health Inc. (ELV), and what drives their investment decisions? In the fourth quarter of 2024, several institutional investors made significant moves: FMR LLC decreased its holdings by 2,426,019 shares, while WELLINGTON MANAGEMENT GROUP LLP increased its position by 1,893,947 shares. Institutional investors have increased holdings from 90.66% to 92.15% in December 2024, and mutual funds have increased holdings from 86.58% to 90.77% in December 2024. With 2839 institutional owners holding a total of 243,107,387 shares, understanding these ownership dynamics can provide valuable insights into the company's stability and future prospects. Let's delve into the investor profile of Elevance Health (ELV) to uncover who's buying, who's selling, and, most importantly, why.

Elevance Health Inc. (ELV) Who Invests in Elevance Health Inc. (ELV) and Why?

Understanding the investor profile of Elevance Health Inc. (ELV) provides key insights into the market's perception of the company and its future prospects. Investors are generally categorized into retail, institutional, and hedge funds, each with different motivations and strategies.

Key Investor Types

• Institutional Investors: These entities, including mutual funds, pension funds, and insurance companies, represent the largest ownership stake in Elevance Health. According to recent data, institutional investors hold a significant portion of Elevance Health's shares. As of December 31, 2024, institutional investors held 93.85% of shares. The largest shareholders include:
  • Vanguard Group Inc: 21.49 million shares
  • BlackRock Inc.: 20.44 million shares
  • State Street Corporation: 10.68 million shares
• Retail Investors: Individual investors who buy and sell shares for their own accounts. While their collective impact is substantial, their individual holdings are typically smaller than those of institutional investors. Public Companies & Retail Investors hold 8.65% of shares.
• Hedge Funds: These are investment partnerships that use pooled funds and may employ various strategies to earn active return, or alpha, for their investors. Hedge fund activity in Elevance Health involves both the addition and reduction of shares. For example, in Q4 2024:
  • WELLINGTON MANAGEMENT GROUP LLP added 1,893,947 shares
  • HARRIS ASSOCIATES L P added 1,821,284 shares
  • FMR LLC removed 2,426,019 shares

Investment Motivations

Different factors attract investors to Elevance Health, influencing their investment decisions.

• Growth Prospects: Elevance Health is seen as a company with strong growth potential, driven by strategic initiatives and market dynamics. The company's focus on personalized healthcare and digital solutions is expected to drive future growth.
• Financial Stability: Elevance Health's sound financial health, highlighted by key financial ratios, makes it an attractive investment. A total debt-to-equity ratio of just 0.05 and a leverage ratio of 2.8 demonstrate robust fiscal control.
• Shareholder Returns: Elevance Health has a history of returning cash to shareholders through dividends and share buybacks. The company has consistently increased its dividend, with a 15.54% dividend growth and a 14-year streak of consecutive dividend increases.
• Market Position: As a leading health benefits company, Elevance Health holds a significant market share and operates as the largest single provider of Blue Cross Blue Shield branded coverage in 14 states.

Investment Strategies

Investors adopt various strategies when investing in Elevance Health, depending on their investment goals and risk tolerance.

• Long-Term Holding: Many institutional investors adopt a long-term holding strategy, driven by Elevance Health's strong fundamentals and growth prospects.
• Value Investing: Some investors are attracted to Elevance Health due to its attractive valuation. The company's shares are considered undervalued, with a medium-term price target of $490 and a long-term target of $600.
• Dividend Investing: Elevance Health's consistent dividend increases and strong dividend yield make it an attractive option for dividend investors.
• Growth Investing: With a focus on strategic initiatives and market dynamics, Elevance Health is also favored by growth investors seeking companies with high growth potential.

The following table summarizes recent trading activity by major shareholders:

Additionally, insider trading activity reveals the following:

• CHARLES MORGAN JR KENDRICK (EVP & President, Commercial) sold 3,504 shares for an estimated $1,388,635.
• RONALD W PENCZEK (CAO & Controller) sold 443 shares for an estimated $183,902.

Members of Congress have also traded ELV stock:

• REPRESENTATIVE JARED MOSKOWITZ: Purchased up to $15,000 and sold up to $45,000.
• REPRESENTATIVE JEFFERSON SHREVE: Purchased up to $50,000.
• REPRESENTATIVE ROBERT BRESNAHAN: Sold up to $15,000.

For more insights into Elevance Health Inc.'s financial standing, explore Breaking Down Elevance Health Inc. (ELV) Financial Health: Key Insights for Investors.

Elevance Health Inc. (ELV) Institutional Ownership and Major Shareholders of Elevance Health Inc. (ELV)

Institutional ownership in Elevance Health Inc. (ELV) reveals significant insights into the company's stability and investor confidence. Monitoring major shareholders and their investment activities provides a glimpse into market sentiment and potential strategic shifts. As of 2024, a substantial portion of Elevance Health Inc. (ELV) shares are held by institutional investors.

Here's a closer look at the institutional ownership of Elevance Health Inc. (ELV):

• Top Institutional Investors: The largest institutional investors in Elevance Health Inc. (ELV) typically include well-known investment firms. While specific shareholdings can fluctuate, these firms often manage considerable stakes.
• Vanguard Group Inc.: As of December 31, 2023, Vanguard Group Inc. holds 12,877,184 shares of Elevance Health Inc. (ELV), representing 5.61% of the company.
• BlackRock Inc.: BlackRock Inc.'s holdings as of December 31, 2023, amount to 11,553,716 shares, accounting for 5.03% of Elevance Health Inc. (ELV).
• State Street Corporation: As of December 31, 2023, State Street Corporation holds 6,224,551 shares, representing approximately 2.71% ownership.
• Changes in Ownership: Recent filings indicate that institutional investors frequently adjust their positions in Elevance Health Inc. (ELV). These changes can reflect evolving investment strategies, market conditions, and company-specific developments.
• Increased Stakes: Some institutional investors have increased their holdings, signaling confidence in Elevance Health Inc. (ELV)’s future prospects.
• Decreased Stakes: Conversely, others have reduced their positions, potentially due to portfolio rebalancing or concerns about the company’s performance.

The following table summarizes the ownership data for major institutional investors in Elevance Health Inc. (ELV) as of December 31, 2023:

Impact of Institutional Investors: The actions of large institutional investors can significantly influence Elevance Health Inc. (ELV)’s stock price. Substantial purchases can drive up demand, while large sales may exert downward pressure.

Additionally, institutional investors often engage with company management on strategic issues, influencing corporate governance and long-term planning. Their insights and expectations can play a role in shaping Elevance Health Inc. (ELV)’s strategic direction and operational decisions.

For more insights into Elevance Health Inc. (ELV)’s financial performance, consider reading Breaking Down Elevance Health Inc. (ELV) Financial Health: Key Insights for Investors.

Elevance Health Inc. (ELV) Key Investors and Their Impact on Elevance Health Inc. (ELV)

Understanding the investor profile of Elevance Health Inc. (ELV) provides valuable insights into the company's stability, growth potential, and strategic direction. Key investors can significantly influence company decisions and stock performance through their holdings and actions.

Institutional investors form a significant portion of Elevance Health Inc.'s (ELV) shareholder base. These entities, which include mutual funds, pension funds, and hedge funds, manage large sums of money on behalf of their clients. Their investment decisions are often driven by in-depth research and analysis, and their actions can have a substantial impact on Elevance Health Inc.'s (ELV) stock price.

Here are some of the top institutional holders of Elevance Health Inc. (ELV) based on recent data:

• Vanguard Group: As one of the largest asset managers globally, Vanguard typically holds a significant stake in Elevance Health Inc. (ELV).
• BlackRock Fund Advisors: Another major player in the investment world, BlackRock's holdings in Elevance Health Inc. (ELV) are closely watched by market analysts.
• State Street Corporation: Known for its index funds and ETFs, State Street often has a considerable position in Elevance Health Inc. (ELV).
• Fidelity Management & Research: A well-known investment firm with a substantial portfolio, Fidelity's investment decisions in Elevance Health Inc. (ELV) are closely monitored.
• Geode Capital Management: This firm often holds a significant number of shares, reflecting its broad investment strategy.

These institutional investors often have a long-term investment horizon, which can provide stability to Elevance Health Inc.'s (ELV) stock. However, significant changes in their holdings can also create volatility.

Activist investors sometimes take positions in Elevance Health Inc. (ELV) with the goal of influencing company strategy or operations. While specific activist involvement can vary, their presence or absence is noteworthy. Here’s what to consider:

• Potential for Change: Activist investors often push for changes such as strategic shifts, cost-cutting measures, or leadership changes.
• Market Reaction: News of activist involvement can cause significant stock movements as other investors speculate on the potential outcomes.

Monitoring the activity of these investors can provide insights into potential shifts in Elevance Health Inc.'s (ELV) direction.

Recent moves by major investors can provide clues about their confidence in Elevance Health Inc.'s (ELV) future prospects. For example:

• Significant Purchases: Large purchases by institutional investors can signal strong confidence in the company's future performance.
• Large Sales: Conversely, substantial sales may indicate concerns about the company's prospects.
• Increased or Decreased Positions: Changes in holdings, as reported in SEC filings, offer insights into investor sentiment.

Keeping an eye on these activities can help in understanding the broader market sentiment towards Elevance Health Inc. (ELV).

Here's a hypothetical snapshot of Elevance Health Inc.'s (ELV) major shareholders and their approximate holdings based on the latest available data for the fiscal year 2024. Please note that these figures are illustrative and may not reflect real-time data.

The influence of these investors can be seen in various aspects of Elevance Health Inc.'s (ELV) operations:

• Corporate Governance: Large institutional investors often have a say in board member elections and other governance matters.
• Strategic Decisions: Their views can influence major strategic decisions, such as mergers, acquisitions, and divestitures.
• Financial Performance: Investor expectations play a crucial role in shaping the company's focus on financial performance and shareholder value.

Understanding who is investing in Elevance Health Inc. (ELV) and why is essential for anyone looking to gain a deeper understanding of the company. By tracking the moves of key investors, one can gain valuable insights into the market sentiment and potential future direction of the company.

To gain more insights into Elevance Health Inc.'s (ELV) mission and values, check out: Mission Statement, Vision, & Core Values of Elevance Health Inc. (ELV).

Elevance Health Inc. (ELV) Market Impact and Investor Sentiment

Understanding investor sentiment and market reactions is crucial for gauging the financial health and future prospects of Elevance Health Inc. (ELV). Shifts in major shareholdings, market responses to these changes, and analyst perspectives all contribute to a comprehensive view of the company's standing.

Investor sentiment toward Elevance Health Inc. (ELV) reflects the overall confidence and expectations of major shareholders. While specific sentiment can fluctuate, monitoring ownership trends provides insights. For instance, significant increases in holdings by institutional investors may indicate a positive outlook, while decreases could suggest concerns about future performance. Recent data on Elevance Health Inc. (ELV)'s major shareholders is detailed below:

• Vanguard Group: Holds 12,474,574 shares, representing 5.61% of the company.
• BlackRock Fund Advisors: Holds 7,866,981 shares, representing 3.54% of the company.
• State Street Global Advisors: Holds 6,004,242 shares, representing 2.70% of the company.

These large institutional holdings often influence market perception due to the scale of their investments and the thorough research backing their decisions.

Market reactions to changes in ownership or large investor moves can significantly impact Elevance Health Inc. (ELV)'s stock price. Positive reactions typically manifest as stock price increases, reflecting investor confidence. Conversely, negative reactions can lead to price declines. Recent market behavior is influenced by various factors, including company performance, industry trends, and broader economic conditions.

For example, strong earnings reports and strategic acquisitions have historically boosted investor confidence, leading to positive market reactions. Conversely, regulatory challenges or weaker-than-expected performance can trigger negative sentiment. Monitoring these reactions helps in understanding the market's immediate assessment of Elevance Health Inc. (ELV)'s prospects.

Analysts' perspectives play a vital role in shaping investor sentiment and influencing market reactions. Analysts provide in-depth research and recommendations, offering insights into the potential impact of key investors on Elevance Health Inc. (ELV)'s future. These perspectives often consider factors such as:

• Financial Performance: Analysis of revenue, earnings, and cash flow.
• Strategic Initiatives: Evaluation of mergers, acquisitions, and new business ventures.
• Industry Trends: Assessment of market dynamics and competitive landscape.
• Regulatory Environment: Insights into healthcare policies and their potential impact.

Analysts' ratings and price targets can significantly influence investor decisions. Upgrades and positive outlooks tend to attract more investors, while downgrades may lead to sell-offs. Keeping abreast of these analyst perspectives is crucial for understanding the broader market sentiment toward Elevance Health Inc. (ELV).

Here's a summary of analyst ratings for Elevance Health Inc. (ELV):

This distribution of ratings provides a snapshot of how analysts currently view Elevance Health Inc. (ELV)'s potential investment value.

Understanding Elevance Health Inc. (ELV)'s mission, vision, and core values provides additional context for long-term investment strategies. Learn more about these aspects at: Mission Statement, Vision, & Core Values of Elevance Health Inc. (ELV).

By analyzing investor sentiment, market reactions, and analyst perspectives, stakeholders can gain a well-rounded understanding of Elevance Health Inc. (ELV)'s market dynamics and potential future performance. This comprehensive approach supports informed decision-making and strategic planning.